Alembic’ Aleor Dermaceuticals receives US FDA tentative approval for Diclofenac Sodium topical…
Diclofenac Sodium Topical Solution USP, 2 per cent w/w is indicated for the treatment of the pain of osteoarthritis of the knee(s)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alembic Pharmaceuticals
US FDA issues one observation for Aleor Dermaceuticals’ Karakhadi unit
The regulator issued one observation after the inspection, as per reports
Alembic reports a 37 per cent hike in net profits
The company reported that its net sales shot up by 10 per cent at Rs 949 cr in Q1 while profit before exceptional items and tax…
Alembic Pharma gets tentative nod from USFDA for glycemic control drug
Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months,…
FDA grants approvals for generic Lyrica
The FDA granted approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal…
Alembic Pharma gets USFDA nod for Febuxostat tablets
The approved product is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals
Alembic Pharma gets US FDA nod for Oseltamivir Phosphate capsules
The approved product is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La Roche
Alembic Pharma gets US FDA nod for ophthalmic solution
The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 per cent,…
Alembic: A century and still going strong
Alembic Pharma has emerged as a renowned player in a thriving industry but not before tracing an eventful journey spanning over a…
Alembic Pharma opens Rs 300 cr facility in Vadodara
With the new anti-cancer facility, the company will expand its presence in the growing global oncology segment